stockrow
Friday 6 November 2026
Export NTRB’s income statement to Excel — free account
Nutriband Inc.
NTRB Healthcare Biotechnology
Nutriband Inc.’s revenue for fiscal 2026 (year ended January 2026) was $2.0 million, down 4.80% from fiscal 2025.
- Revenue
- −29.7%
- EPS
- +96.7%
- Free cash flow
- +55.5%
- Total debt
- −46.9%
Quarter to July 2026, against a year earlier
5.57
0.01
−0.18%
Follow NTRB
Alert me
| Jan '26 | Jan '25 | Jan '24 | Jan '23 | Jan '22 | Jan '21 | Jan '20 | Jan '19 | Jan '18 | Jan '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 4 | 4 | 4 | 5 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Altman Z-Score |
27.17 | 39.83 | 4.48 | 16.55 | 17.24 | 19.43 | 12.59 | 222.68 | — | — |
P/S ratio |
26.81 | 41.10 | 9.96 | 14.85 | 20.92 | 110.08 | 201.26 | 0.00 | — | — |
Altman Z″-Score (non-manufacturers) |
(15.84) | (16.21) | (10.20) | 0.60 | 8.72 | (4.48) | (25.04) | (8.45) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Beneish M-Score |
(3.51) | (6.85) | (3.52) | (2.60) | (3.79) | (1.09) | — | — | — | — |
P/Operating CF |
(74.61) | (70.96) | (28.91) | (37.93) | (24.14) | (1,248.68) | (634.42) | (545.00) | — | — |
P/B ratio |
8.18 | 13.68 | 3.22 | 3.60 | 2.51 | 14.61 | 425.36 | 64.12 | — | — |
Price to Tangible BV |
11.48 | 19.77 | 27.71 | 11.14 | 5.33 | 0.00 | 0.00 | 462.17 | — | — |
EV/Sales |
24.61 | 39.14 | 9.79 | 13.97 | 17.60 | 110.25 | 201.42 | 0.00 | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
EV/Operating CF |
(9.76) | (18.10) | (5.79) | (9.73) | (8.91) | (350.23) | (83.47) | (139.05) | — | — |
EV/FCF |
(9.75) | (17.75) | (5.70) | (9.48) | (8.66) | (345.35) | (83.08) | (138.53) | — | — |
Quick Ratio |
5.98 | 4.46 | 0.64 | 2.80 | 6.37 | 0.10 | 0.01 | 1.21 | 0.01 | 1.87 |
Current Ratio |
6.36 | 4.88 | 1.02 | 3.60 | 7.01 | 0.12 | 0.02 | 1.47 | 3.80 | 2.58 |
Net Debt/EBITDA |
0.56 | 0.67 | 0.09 | 0.50 | 1.36 | (0.04) | (0.03) | 0.13 | (0.18) | 0.11 |
Debt/Assets |
0.48% | 0.78% | 1.06% | 1.06% | 0.79% | 2.49% | 3.07% | 1.42% | 18.86% | 27.85% |
Debt/Equity |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.38 | 0.02 | 0.26 | 0.45 |
Asset Turnover |
0.27 | 0.29 | 0.25 | 0.19 | 0.13 | 0.16 | 0.15 | 0.17 | 0.00 | 0.00 |
Operating CF/Net income |
0.17 | 0.44 | 0.64 | 0.67 | 0.44 | 0.10 | 0.33 | 0.33 | 0.03 | 0.98 |
Capex/Depreciation |
(0.02) | (0.02) | (0.16) | (0.11) | (0.03) | 0.00 | 0.00 | (0.11) | 0.00 | — |
Interest Coverage |
(369.69) | (480.60) | (64.27) | (539.18) | (51.61) | (9.25) | (26.83) | — | — | — |
| (458.49%) | (162.94%) | (73.08%) | (43.89%) | (67.18%) | (80.49%) | (210.98%) | (263.74%) | (3,695.57%) | (2,608.62%) | |
| (400.11%) | (139.89%) | (64.63%) | (40.40%) | (56.23%) | (48.38%) | (108.75%) | (224.13%) | (2,637.61%) | (796.32%) | |
ROIC |
(242.88%) | (295.49%) | (50.54%) | (41.82%) | (54.03%) | (22.51%) | (528.95%) | (105.69%) | (1,094.32%) | (1,454.81%) |
Return on Tangible Assets |
(629.62%) | (232.61%) | (687.64%) | (157.71%) | (112.48%) | 249.01% | 145.69% | (998.56%) | (2,199.09%) | (654.98%) |
Average Days of Receivables |
21.22 | 12.59 | 26.01 | 19.83 | 18.32 | 42.27 | 12.61 | 19.49 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
92.85% | 145.79% | 94.01% | 47.23% | 28.93% | 0.00% | 0.00% | 0.00% | — | — |
Selling, General and Administrative Expense of Revenue |
343.35% | 201.63% | 180.96% | 188.31% | 282.86% | 308.60% | 483.27% | 1,340.48% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.25 | 0.27 | 0.76 | 0.61 | 0.49 | 0.86 | 0.93 | 0.74 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
134.45% | 72.09% | 35.62% | 35.20% | 63.13% | 0.00% | 68.19% | 719.12% | — | 0.00% |
Graham Net Nets |
0.08 | 0.04 | 0.00 | 0.06 | 0.15 | (0.02) | (0.03) | 0.00 | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Earnings Yield |
(56.35%) | (11.94%) | (26.44%) | (15.07%) | (21.49%) | (2.88%) | (3.60%) | (2.16%) | — | — |
Free Cash Flow Yield |
(9.41%) | (5.37%) | (17.24%) | (9.93%) | (9.72%) | (0.29%) | (1.20%) | (0.72%) | — | — |
Revenue per Share |
0.18 | 0.20 | 0.26 | 0.25 | 0.18 | 0.14 | 0.06 | 0.04 | 0.00 | 0.00 |
Operating CF per Share |
(0.44) | (0.44) | (0.44) | (0.35) | (0.35) | (0.04) | (0.14) | (0.18) | 0.00 | (0.01) |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.01) | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.44) | (0.44) | (0.45) | (0.36) | (0.36) | (0.04) | (0.14) | (0.18) | 0.00 | (0.01) |
Cash per Share |
0.39 | 0.41 | 0.06 | 0.23 | 0.62 | 0.02 | 0.00 | 0.08 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.57 | 0.61 | 0.81 | 1.01 | 1.50 | 1.06 | 0.03 | 0.39 | 0.01 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.57 | 0.61 | 0.81 | 1.01 | 1.50 | 1.06 | 0.03 | 0.39 | 0.01 | 0.00 |
Free Cash Flow |
(5.14) | (4.72) | (3.58) | (3.07) | (2.89) | (0.30) | (0.89) | (1.11) | (0.09) | (0.15) |
Working Capital |
4.20 | 3.81 | 0.02 | 1.95 | 4.69 | (2.25) | (1.98) | 0.19 | 0.12 | 0.02 |
Capital Expenditures |
(0.01) | (0.09) | (0.05) | (0.08) | (0.08) | — | — | 0.00 | — | — |
Net Current Asset Value |
4.12 | 3.75 | (0.06) | 1.81 | 4.59 | (2.50) | (1.98) | 0.19 | 0.12 | 0.02 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Capex to Sales |
0.00 | 0.04 | 0.02 | 0.04 | 0.06 | 0.00 | 0.00 | 0.02 | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.41 | 5.63 | 0.41 | 0.78 | 2.65 | 0.41 | 1.43 | 0.25 | 0.00 | — |
Cash ROIC |
(45.52%) | (43.70%) | (51.05%) | (28.77%) | (17.15%) | (3.96%) | (353.42%) | (38.01%) | (60.88%) | (243.66%) |
Accounts Receivable Turnover |
21.19 | 19.24 | 15.94 | 22.56 | 15.74 | 15.46 | 28.62 | 36.61 | 0.00 | 0.00 |
Accounts Payable Turnover |
2.45 | 2.03 | 2.01 | 2.26 | 1.16 | 0.73 | 1.03 | 1.90 | 0.00 | 0.00 |
Inventory Turnover |
8.91 | 7.34 | 6.15 | 7.37 | 9.95 | 22.05 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
124.79 | 182.68 | 202.94 | 146.83 | 254.32 | 547.21 | 513.10 | 369.43 | 0.00 | 0.00 |
Days of Inventory on Hand |
29.29 | 55.42 | 50.31 | 62.97 | 52.34 | 30.72 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.10 | 0.11 | 0.13 | 0.09 | 0.09 | 0.06 | 0.01 | 0.01 | 0.00 | 0.00 |
Average Payables |
0.60 | 0.69 | 0.61 | 0.59 | 0.79 | 0.86 | 0.53 | 0.15 | 0.01 | 0.00 |
Average Inventory |
0.17 | 0.19 | 0.20 | 0.18 | 0.09 | 0.03 | — | — | 0.01 | 0.01 |
Average Assets |
7.51 | 7.49 | 8.49 | 11.10 | 11.33 | 6.06 | 2.50 | 1.49 | 0.10 | 0.02 |
Average Common Equity |
6.55 | 6.43 | 7.51 | 10.22 | 9.49 | 3.64 | 1.29 | 1.26 | 0.07 | 0.01 |
Columns are period end dates